Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PLx Pharma Inc. | Chief Executive Officer, Director | Common Stock | 5.19K | $18.9K | $3.65 | Mar 15, 2022 | Direct |
Matinas BioPharma Holdings, Inc. | Director | Stock option (right to buy) | 437K | Nov 1, 2023 | Direct | ||
PLx Pharma Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 300K | Feb 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MTNB | Matinas BioPharma Holdings, Inc. | Nov 1, 2023 | 1 | $0 | 4 | Nov 3, 2023 | Director |
MTNB | Matinas BioPharma Holdings, Inc. | Nov 14, 2022 | 1 | $0 | 4 | Nov 16, 2022 | Director |
PLXPQ | PLx Pharma Inc. | Mar 15, 2022 | 1 | $15K | 4 | Mar 16, 2022 | Chief Executive Officer, Director |
PLXPQ | PLx Pharma Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Chief Executive Officer, Director |
MTNB | Matinas BioPharma Holdings, Inc. | Nov 1, 2021 | 1 | $0 | 4 | Nov 2, 2021 | Director |
PLXPQ | PLx Pharma Inc. | Aug 9, 2021 | 1 | $0 | 4 | Aug 11, 2021 | Chief Executive Officer, Director |